Previous studies on MCP-4 have mainly focused on inflammatory diseases, however, more recent studies have reported that the expression of MCP-4 is increased in colorectal (7) and gastric cancers (8), which are associated with the development of malignant tumors. This evidence concerns the gene CCL13 and cancer.